A UHPLC–MS/MS Method Reveals the Pharmacokinetics of Deacetyl Asperulosidic Acid Methyl Ester in Rats
- 7 February 2025
- journal article
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (3) , e70001
Abstract
In the current study, a simple ultra‐high performance liquid chromatography–tandem mass spectrometry method was developed and fully validated for the quantitation of deacetyl asperulosidic acid methyl ester in rat plasma. The plasma sample was precipitated with acetonitrile and then separated on the Waters ACQUITY UPLC HSS T3 column. The mobile phases, water and acetonitrile, were added with 0.1% formic acid. The mass spectrometry detection was performed in negative‐ion multiple reaction monitoring. In the range of 1–1000 ng/mL, the linearity meets the requirements with correlation coefficient more than 0.99. The parameters of accuracy, precision, carryover, matrix effect, extraction recovery, stability, and dilution integrity are within accepted ranges. The validated method has been successfully used for pharmacokinetic study of deacetyl asperulosidic acid methyl ester in rats. After oral administration, deacetyl asperulosidic acid methyl ester was quickly absorbed into blood and reached the maximum plasma drug concentration of 4047.49 ng/mL at 2 h. The half‐life of deacetyl asperulosidic acid methyl ester is 5.6 h, which suggests that it has a moderate metabolic process. Since the absolute bioavailability of deacetyl asperulosidic acid methyl ester is only 3.74%, its gastrointestinal stability, first‐pass effect, and transmembrane properties remain to be studied.Keywords
Funding Information
- National Natural Science Foundation of China (82104541, 82104873, 82274408, 82104326)
This publication has 24 references indexed in Scilit:
- Pharmacokinetic study of iptacopan and its two acyl glucuronide metabolites in monkey plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometryBiomedical Chromatography, 2024
- Ultrahigh‐performance liquid chromatography Q‐Exactive‐Orbitrap mass spectrometry and molecular network analysis alongside network pharmacology to elucidate the active constituents and mechanism of action of Huahong tablet in treating pelvic inflammatory diseaseRapid Communications in Mass Spectrometry, 2024
- Why 90% of clinical drug development fails and how to improve it?Acta Pharmaceutica Sinica B, 2022
- Pharmacokinetic studies of ginsenosides Rk1 and Rg5 in rats by UFLC–MS/MSBiomedical Chromatography, 2021
- Dynamic changes in chemical compositions and anti‐acetylcholinesterase activity associated with steaming process of stem‐leaf saponins of Panax notoginsengBiomedical Chromatography, 2021
- Structural characterization and anticomplement activity of an acidic polysaccharide from Hedyotis diffusaInternational Journal of Biological Macromolecules, 2020
- Identification and characterization of forced degradation products and stability‐indicating assay for notoginsenosidefc by using UHPLC‐Q‐TOF‐MS and UHPLC‐MS/MS: Insights into stability profile and degradation pathwaysJournal of Separation Science, 2019
- Characterization of multiple absorbed constituents in rats after oral administration of Paederia scandens decoctionBiomedical Chromatography, 2011
- Simultaneous quantification of three iridoids in rat plasma after oral administration of Zhi‐zi‐chi decoction using LC‐MSJournal of Separation Science, 2011
- Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometryJournal of Chromatography B, 2008